BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer Cambridge, Business
Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX Cambridge, Business
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors Cambridge, Business
Electronica "Third Thursdays" in Aug.w/host D. Bryant (keys), N. Leonard (saxes), B. Råberg (bass) Cambridge
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy Cambridge, Business
Sage Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022 Cambridge, Business
ROME Therapeutics Appoints Industry Veteran Jeff Hatfield as Chair of Board of Directors Cambridge, Business
LG Chem Announces First Subject Enrolled in Phase 1 Clinical Trial of NASH New Drug Cambridge, Business
Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio Cambridge, Business
SiTration Raises $2.35 Million in Pre-Seed Funding to Revolutionize Battery Recycling for Electric Vehicles Cambridge, Business
Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer Cambridge, Business
Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts Cambridge, Business
Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA) Cambridge, Business
PineTree Therapeutics, Inc. Secures $23.5 Million of Series A1 Funding to Develop Cutting Edge Platform Technology to Create Therapeutic Assets for Unmet Medical Needs Cambridge, Business
Bicara Therapeutics Presents Data from Dose Escalation Portion of Ongoing Phase 1/1b Trial of Lead Bifunctional Program, BCA101, at the American Society of Clinical Oncology 2022 Annual Meeting Cambridge, Business